Cancer BiologyMolecular CancerPeer-reviewed
LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAFV600E colorectal cancer
Christopher A. Ladaika, Averi Chakraborty, Ashiq Masood…·Heather M. O’Hagan
This study shows that LSD1 inhibition reduces lineage plasticity caused by BRAF and EGFR inhibitors in BRAFV600E colorectal cancer.
7 citations